Cost impact of self-measurement of blood glucose on complications of type 2 diabetes: The spanish perspective

Diabetes Technology and Therapeutics

Volumn 11, Issue 8, 2009, Pages 509-516

  Neeser, Kurt ^a   Weber, Christian ^a  

^a Institute for Medical Informatics and Biostatistics   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; GLITAZONE DERIVATIVE; GLUCOSE; INSULIN; METFORMIN; SULFONYLUREA;

ANGIOGRAPHY; ARTERY DISEASE; ARTICLE; BLINDNESS; BYPASS SURGERY; CAROTID ENDARTERECTOMY; CATARACT EXTRACTION; CLINICAL ASSESSMENT; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DEPRESSION; DIABETES MELLITUS; DIALYSIS; DRUG COST; FEMALE; FOLLOW UP; FOOT AMPUTATION; FOOT ULCER; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPOGLYCEMIA; ISCHEMIC HEART DISEASE; LASER COAGULATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYNEUROPATHY; PRIORITY JOURNAL; RETINA; SELF MONITORING; SPAIN; STROKE; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; BLOOD GLUCOSE SELF-MONITORING; BLOOD PRESSURE; CHOLESTEROL; COSTS AND COST ANALYSIS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MORBIDITY; REGRESSION ANALYSIS; SPAIN; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 70349470704     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2008.0139     Document Type: Article

References (33)

1. Jimenez-Garcia R, Jimenez-Trujillo I, Hernandez-Barrera V, Carrasco-Garrido P, Lopez A, Gil A: Ten-year trends in selfrated health among Spanish adults with diabetes, 1993 2003. Diabetes Care 2008;31:90-92.
2. Oliva J, Lobo F, Molina B, Monereo S: Direct health care costs of diabetic patients in Spain. Diabetes Care 2004;27:2616-2621.
3. Jonsson B: Revealing the cost of Type II diabetes in Europe. Diabetologia 2002;45:S5-S12.
4. Ballesta M, Carral F, Olveira G, Giron JA, Aguilar M: Economic cost associated with type II diabetes in Spanish patients. Eur J Health Econ 2006;7:270-275.
5. Coster S, Gulliford MC, Seed PT, Powrie JK, Swaminathan R: Self-monitoring in Type 2 diabetes mellitus: A metaanalysis. Diabet Med 2000;17:755-761.
6. Schwedes U, Siebolds M, Mertes G: Meal-related structured self-monitoring of blood glucose: Effect on diabetes control in non-insulin-treated type 2 diabetic patients1. Diabetes Care 2002;25:1928-1932.
7. Guerci B, Drouin P, Grange V, Bougneres P, Fontaine P, Kerlan V, Passa P, Thivolet C, Vialettes B, Charbonnel B: Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: The Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003;29:587-594.
8. Barnett AH, Krentz AJ, Strojek K, Sieradzki J, Azizi F, Embong M, Imamoglu S, Perusicova J, Uliciansky V, Winkler G: The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study). Diabetes Obes Metab 2008;10:1239-1247.
9. Sarol JN, Nicodemus NA, Tan KM, Grava MB: Selfmonitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: A meta-analysis (1966-2004). CurrMed Res Opin 2005;21:173-183.
10. Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WA, Bouter LM: Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin. Cochrane Database Syst Rev 2005;(2):CD005060.
11. Jansen JP: Self-monitoring of glucose in type 2 diabetes mellitus: A Bayesian meta-analysis of direct and indirect comparisons. Curr Med Res Opin 2006;22:671-681.
12. Poolsup N, Suksomboon N, Jiamsathit W: Systematic review of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients. Diabetes Technol Ther 2008;10(Suppl 1):S-51-S-66.
13. Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, Kolb H, Scherbaum WA: Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: An epidemiological cohort study. Diabetologia 2006;49:271-280.
14. Russell S, Antonanzas F, Mainar V: Impact of the Taxus coronary stent: Implications for the Spanish healthcare system. Rev Esp Cardiol 2006;59:889-896.
15. Weber C, Schneider B, Lodwig V, Holm MV, Neeser K: Cost impact of blood glucose self-monitoring on complications of type 2 diabetes: A Swiss perspective (ROSSO study No.11). Swiss Med Wkly 2007;137:545-550.
16. Pinol C, Roze S, Valentine W, Evers T: [Cost-effectiveness of the addition of acarbose to the treatment of patients with type-2 diabetes in Spain]. Gac Sanit 2007;21:97-104.
17. Ministerio de Sanidad y Consumo: Pesos de los GDRs del Sistema Nacional de Salud 2005. Ministerio de Sanidad y Consumo, Madrid, 2008.
18. Pinol C: Análisis coste-efectividad del acido acetilsalicilico frente al clopidogrel en prevencion secundaria tras infarto agudo de miocardio. Pharmacoeconomics Sp Res Art 2005;2: 101-110.
19. Brosa M, Perez V, Comas A, Segu J: The cost-effectiveness of three therapeutic classes in the treatment of major depressive disorder in Spain. Rev Esp Econ Salud 2008;7: 165-172.
20. Carral F, Aguilar M, Olveira G, Mangas A, Domenech I, Torres I: Increased hospital expenditures in diabetic patients hospitalized for cardiovascular diseases. J Diabetes Complications 2003;17:331-336.
21. Garcia L: Coste efectividad de la tomografia computerizada munticorte en el diagnóstico de la estenosis coronaria. XXVII Jornadas de Economia de la Salud, Salamanca 2008. Gac Sanit 2008;22(Suppl 2):9-49.
22. Arrebola-Lopez M, Hernandez-Osma E, Gomez-Moya B, Rodriguez-Espinosa N, Panella-Agusti F, dmetller- Castiglione X, Garcia-Vidal R, Martin-Paredero V: [Carotid stenosis in high risk patients. The SAPPHIRE study versus a decision analysis. Which is the best therapeutic option?]. Rev Neurol 2005;40:449-452.
23. Martinez DA, Aguayo J, Morales G, Aguiran M, Illan F: [Impact of a clinical pathway for the diabetic foot in a general hospital]. An Med Interna 2004;21:420-424.
24. Consejeria de Hacienda y Presupuesto Decreto 218/2006 de 26 de diciembre. Diario Oficial de Extremadura 30 diciembre 2006 n8153. Junta de Extremadura, Merida, 2008.
25. ResolucióSLT/2273/2007, de 28 de Junio. Diari Oficial de la Generalitat de Catalunya n8 4932. Departament de Salut, Barcelona, 2007.
26. Red GEDAPS: Atencion primaria y Diabetes Mellitus tipo 2 en España. Un programa de mejora continua de la calidad asistencial. Educacion Diabetologica Profesional 2005;15:29-33.
27. Informacion sobre los Productos Incluidos en la Prestacion Farmaceutica del SNS. Ministerio de Sanidad y Consumo, Madrid, 2008.
28. Ruiz M, Escolar A, Mayoral E: La diabetes mellitus en España: Mortalidad, prevalencia, incidencia, costes econo micos y desigualdades. Gac Sanit 2006;20(Suppl 1):15-24.
29. Goday A, Flores JA, Chillaron JJ, Cano JF: Epidemiologia de la diabetes tipo 2. Cifras y retos de una enfermedad en continua expansion. Med Clin Monogr (Barcelona) 2008;9:3-7.
30. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-444.
31. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall study. Br Med J (Clin Res Ed) 1983;287:867-870.
32. McAndrew L, Schneider SH, Burns E, Leventhal H: Does patient blood glucose monitoring improve diabetes control? A systematic review of the literature. Diabetes Educ 2007;33:991-1011.
33. McGeoch G, Moore RA: Self-monitoring of blood glucose in type-2 diabetes: What is the evidence? Diabetes Metab Res Rev 2007;23:423-440.